Rest EZ Inc. reported its financial results for the three and nine months ended December 31, 2024, revealing a net loss of $7,867 for the quarter and $7,900 for the nine-month period. This marks a significant increase in losses compared to the same periods in the previous fiscal year, where the company recorded a net loss of $1,184 for the quarter and $23,523 for the nine months ended December 31, 2023. The company did not generate any revenue during these periods, maintaining a consistent trend from the previous year.
Operating expenses for the three months ended December 31, 2024, totaled $7,867, a substantial increase from $1,020 in the same quarter of 2023. For the nine-month period, operating expenses were $7,900, compared to $17,691 in the prior year. The increase in operating expenses is attributed to general and administrative costs, which have risen as the company continues to establish its market presence. The company’s accumulated deficit as of December 31, 2024, stood at $287,792, reflecting ongoing financial challenges.
In terms of operational developments, Rest EZ Inc. has been focused on the production and distribution of its sole product, the Rest EZ Sleep Aid Supplement, a liquid gel capsule. The company has not yet distributed this product widely, with no sales reported during the latest quarter. However, it has sold a total of 77,694 bottles for $664,943 in total sales since its inception. The company is currently in full production and distribution stages, targeting wholesalers and retailers, as well as online sales through its website.
The company’s financial position raises concerns about its ability to continue as a going concern. As of December 31, 2024, Rest EZ Inc. reported a net working capital deficit of $3,018. The management has indicated that without additional capital, the company may struggle to sustain operations. The company is actively seeking investment opportunities and financing options to support its business objectives.
Looking ahead, Rest EZ Inc. plans to enhance its marketing efforts and expand its reach to additional wholesalers and retail chain stores. The company aims to build its reputation and increase sales through direct marketing strategies. However, the management acknowledges that the competition in the dietary supplement market is significant, and the company’s success will depend on its ability to generate sufficient revenue and manage its operational costs effectively.
About REST EZ Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.